News

Morgan Stanley Maintains a Buy Rating on LifeStance Health (LFST), Keeps the PT at $10
LifeStance Health Group, Inc. (NASDAQ: LFST) is one of the 13 Stocks Under $5 With High Upside Potential. On May 27, Morgan ...
William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating
Harrow, Inc. (NASDAQ:HROW) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 10, William ...